ArticleEuropean journal of nuclear medicine and molecular imaging2026
Long term prognostic value of coronary atherosclerotic burden, myocardial perfusion and coronary flow capacity by
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe assessed the long-term prognostic value of the combined evaluation coronary atherosclerotic burden, myocardial perfusion coronary and flow capacity (CFC) derived from
methodsWe studied 5285 patients with suspected or known CAD who underwent to stress/rest cardiac
resultsDuring a mean time of 43 ± 26 months, 683 events occurred (13% cumulative event rate, with an AER of 2.9% person-years). The events were 127 (19%) cardiac death, 250 (37%) myocardial infarction and 306 (45%) coronary revascularizations. In patients with previous history of CAD angina, stress TPD, MFR and CFC resulted predictors of events (all P < 0.001). Differently, in patients without CAD diabetes, CAC score ≥ 400, stress TPD ≥ 5%, MFR < 2 and impaired CFC resulted as independent predictors. Weibull analysis showed that patients with known CAD, stress TPD ≥ 5%, MFR < 2 and impaired CFC had the highest probability of events.
conclusionThe combined evaluation of myocardial perfusion and CFC can predict outcome in both patients with and without known CAD.
Indexed as
Identifiers
41699277What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.